185 related articles for article (PubMed ID: 37877513)
21. Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration.
Banella C; Ginevrino M; Catalano G; Fabiani E; Falconi G; Divona M; Curzi P; Panetta P; Voso MT; Noguera NI
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):163-168. PubMed ID: 32199932
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
23. The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens.
Mundt KA; Dell LD; Boffetta P; Beckett EM; Lynch HN; Desai VJ; Lin CK; Thompson WJ
BMC Cancer; 2021 Mar; 21(1):227. PubMed ID: 33676443
[TBL] [Abstract][Full Text] [Related]
24. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
25. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
26. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K
PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723
[TBL] [Abstract][Full Text] [Related]
27. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
[No Abstract] [Full Text] [Related]
30. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
31. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis.
Teras LR; Patel AV; Carter BD; Rees-Punia E; McCullough ML; Gapstur SM
Br J Haematol; 2019 Jul; 186(2):243-254. PubMed ID: 30977126
[TBL] [Abstract][Full Text] [Related]
32. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
33. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study.
Frederiksen H; Farkas DK; Christiansen CF; Hasselbalch HC; Sørensen HT
Blood; 2011 Dec; 118(25):6515-20. PubMed ID: 22039256
[TBL] [Abstract][Full Text] [Related]
34. Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018.
Park WJ; Park JH; Cho S; Shin MG
Blood Res; 2021 Dec; 56(4):301-314. PubMed ID: 34880144
[TBL] [Abstract][Full Text] [Related]
35. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.
Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E
Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125
[TBL] [Abstract][Full Text] [Related]
36. Pyoderma gangrenosum in hematologic malignancies: A systematic review.
Montagnon CM; Fracica EA; Patel AA; Camilleri MJ; Murad MH; Dingli D; Wetter DA; Tolkachjov SN
J Am Acad Dermatol; 2020 Jun; 82(6):1346-1359. PubMed ID: 31560977
[TBL] [Abstract][Full Text] [Related]
37. Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer.
Nebgen DR; Rhodes HE; Hartman C; Munsell MF; Lu KH
Obstet Gynecol; 2016 Aug; 128(2):357-363. PubMed ID: 27400009
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related myeloid neoplasms following treatment with radioiodine.
Schroeder T; Kuendgen A; Kayser S; Kröger N; Braulke F; Platzbecker U; Klärner V; Zohren F; Haase D; Stadler M; Schlenk R; Czibere AG; Bruns I; Fenk R; Gattermann N; Haas R; Kobbe G; Germing U
Haematologica; 2012 Feb; 97(2):206-12. PubMed ID: 21993688
[TBL] [Abstract][Full Text] [Related]
39. Incidence of non-Hodgkin's lymphoma among adults in Sardinia, Italy.
Broccia G; Carter J; Ozsin-Ozler C; Meloni F; De Matteis S; Cocco P
PLoS One; 2022; 17(2):e0260078. PubMed ID: 35108286
[TBL] [Abstract][Full Text] [Related]
40. [Incidence of neoplasms of the hematologic and lymphoreticular systems in Lower Silesia 1972-1985. I. Incidence in the entire region].
Kotlarek-Haus S; Waszkiewicz L; Kin-Dittmann I; Błaczkowska A
Acta Haematol Pol; 1990; 21(2):173-84. PubMed ID: 2131717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]